Demura Yoshiki, Tsuchida Tatsuro, Ishizaki Takeshi, Mizuno Shiro, Totani Yoshitaka, Ameshima Shingo, Miyamori Isamu, Sasaki Masato, Yonekura Yoshiharu
Third Department of Internal Medicine, Fukui Medical University, 23 Matsuoka-cho, Fukui Pref 910-11, Japan.
J Nucl Med. 2003 Apr;44(4):540-8.
Recent reports have indicated the value and limitations of (18)F-FDG PET and (201)Tl SPECT for determination of malignancy. We prospectively assessed and compared the usefulness of these scintigraphic examinations as well as (18)F-FDG PET delayed imaging for the evaluation of thoracic abnormalities.
Eighty patients with thoracic nodular lesions seen on chest CT images were examined using early and delayed (18)F-FDG PET and (201)Tl-SPECT imaging within 1 wk of each study. The results of (18)F-FDG PET and (201)Tl SPECT were evaluated and compared with the histopathologic diagnosis.
Fifty of the lesions were histologically confirmed to be malignant, whereas 30 were benign. On (18)F-FDG PET, all malignant lesions showed higher standardized uptake value (SUV) levels at 3 than at 1 h, and benign lesions revealed the opposite results. Correlations were seen between (18)F-FDG PET imaging and the degree of cell differentiation in malignant tumors. No significant difference in accuracy was found between (18)F-FDG PET single-time-point imaging and (201)Tl SPECT for the differentiation of malignant and benign thoracic lesions. However, the retention index (RI) of (18)F-FDG PET (RI-SUV) significantly improved the accuracy of thoracic lesion diagnosis. Furthermore, (18)F-FDG PET delayed imaging measuring RI-SUV metastasis was useful for diagnosing nodal involvement and it improved the specificity of mediastinal staging.
No significant difference was found between (18)F-FDG PET single-time-point imaging and (201)Tl SPECT for the differentiation of malignant and benign thoracic lesions. The RI calculated by (18)F-FDG PET delayed imaging provided more accurate diagnoses of lung cancer.
近期报告指出了(18)F-FDG PET和(201)Tl SPECT在确定恶性肿瘤方面的价值和局限性。我们前瞻性地评估并比较了这些闪烁显像检查以及(18)F-FDG PET延迟显像对胸部异常的评估作用。
对80例胸部CT图像上发现有结节性病变的患者,在每项研究的1周内进行早期和延迟(18)F-FDG PET及(201)Tl-SPECT显像。评估(18)F-FDG PET和(201)Tl SPECT的结果,并与组织病理学诊断进行比较。
50个病变经组织学证实为恶性,30个为良性。在(18)F-FDG PET上,所有恶性病变在3小时时的标准化摄取值(SUV)水平高于1小时时,而良性病变结果相反。(18)F-FDG PET显像与恶性肿瘤的细胞分化程度之间存在相关性。在鉴别胸部恶性和良性病变方面,(18)F-FDG PET单时间点显像与(201)Tl SPECT的准确性无显著差异。然而,(18)F-FDG PET的滞留指数(RI)(RI-SUV)显著提高了胸部病变诊断的准确性。此外,(18)F-FDG PET延迟显像测量RI-SUV转移对诊断淋巴结受累有用,并提高了纵隔分期的特异性。
在鉴别胸部恶性和良性病变方面,(18)F-FDG PET单时间点显像与(201)Tl SPECT无显著差异。(18)F-FDG PET延迟显像计算的RI能更准确地诊断肺癌。